Acquiring Company
CONMED Corporation
Acquired Company
In2Bones Global
Tampa BayManufacturingBiotechnologyHealth CareMedicalMedical DeviceImage RecognitionManufacturingHealth CareDescription
CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval, and is expected to close late in the second quarter or early in the third quarter of 2022.
Quick answer
CONMED Corporation is acquiring In2Bones Global, announced May 4, 2022. CONMED Corporation is based in Tampa Bay, Florida, United States.
- How much did CONMED Corporation pay for In2Bones Global?
- The deal value was not disclosed.
- What does CONMED Corporation do?
- CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.
- Where are CONMED Corporation and In2Bones Global based?
- CONMED Corporation is based in Tampa Bay, Florida, United States.
- Who are the decision-makers at CONMED Corporation?
- Fundz holds 1 contact at CONMED Corporation. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Halozyme Completes Antares Pharma Acquisition (May 24, 2022)
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
- Bristol Myers Squibb To Acquire Turning Point Therapeutics, A Leading Precision Oncology Company (June 3, 2022)
- Masimo Closes Acquisition Of Sound United (April 12, 2022)
- Zoetis Announces Agreement To Acquire Basepaws, An Innovative Leader In Petcare Genetics, To Strengthen Its Portfolio Of Precision Animal Health Solutions (June 7, 2022)
Who to call at CONMED Corporation, and when
When CONMED Corporation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CONMED Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CONMED Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CONMED Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CONMED Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired In2Bones Global?
In2Bones Global was acquired by CONMED Corporation, based in Tampa Bay. The deal was reported on May 4, 2022. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. CONMED Corporation is publicly traded (CNMD) and operates in Manufacturing.
When did CONMED Corporation acquire In2Bones Global?
CONMED Corporation's acquisition of In2Bones Global was reported on May 4, 2022. CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does In2Bones Global do?
Headquartered in Memphis, Tennessee, In2Bones is a global developer manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.